4
Tetrahedron
C. J. Nat. Prod. 1988, 51, 599; (h) Chao, J. Y.; Sook Yoo, K. U. B. E.; Yoshikawa, K.; Park, M. H. J. Nat. Prod. 2000, 63, 1205 (i) Borsato, M. L.
C.; Grael, C. F. F.; Souza, G. E. P.; Lopes, N. P. Phytochemistry 2000, 55, 809; (j) Kemp, M. S.; Burden, R. S. Phytochemistry 1986, 25, 1261; (l)
Ukita, T.; Sugahara, M.; Terakawa, Y.; Kuroda, T.; Wada, K.; Nakata, A.; Ohmachi, Y.; Kikkawa, H.; Ikezawa, K.; Naito, K. J. Med. Chem. 1999,
4
2, 1088; (m) Ukita, T.; Nakamura, Y.; Kubo, A.; Yammato, Y.; Takahashi, M.; Kotera, J.; Ikeo, T. J. Med. Chem. 1999, 42, 1293; (n) Ademar, A.
F.; Albuquerque, S.; Silva, L. A.; Eberlin, M. N.; Tomazela, M.; Bastos, K. J. Nat. Prod. 2004, 67, 42; (o) Ramos, A. C.; Pelaez-Lamamie de Clairac,
R.; Medarde, M. Heterocycles 1999, 51, 1443; (p) Leteurtre, F.; Madalengoitia, J.; Orr, A.; Guzi, T.; Lehnert, E.; Macdonald, T.; Pommier, Y. Cancer
Res. 1992, 52, 4478; (q) Tepe, J. J.; Madalengoitia, J. S.; Slunt, K. M.; Werbovetz, K. A.; Grant Spoors, P.; Macdonald, T. L. J. Med. Chem. 1996, 39,
2
188; (r) Madalengoitia, J. S.; Tepe, J. J.; Werbovetz, K. A.; Lehnert, E.; Macdonald, T. L. Bioorg. Med. Chem. 1997, 5, 1807.
2
.
(a) Damayanthi, Y.; Lown, J. W. Curr. Med. Chem. 1998, 5, 205; (b) Lisiecki, K.; Krawczyk, K. K.; Piotr R.; Jan K. M.; Czarnocki, Z. Org. Biomol.
Chem. 2016, 14, 460.
3
4
5
.
.
.
Park, J.-E.; Lee, J.; Seo, S.-Y.; Shin, D. Tetrahedron Lett. 2014, 55, 818.
Madalengoitia, J. S.; Macdonald, T. M. Tetrahedron Lett. 1993, 34, 6237.
(a) Schmidt, D. G.; Seemuth, P. D.; Zimmer, H. J. Org. Chem. 1983, 48, 1914; (b) Tomioka, K.; Kubota, Y.; Kawasaki, H.; Koga, K. Tetrahedron
Lett. 1989, 30, 2949; (c) Medarde, M.; Lamamié de Clairac, R. P.; Tomé, F.; Lopez, J. L.; Feliciano, A. S. Arch. Pharm. (Weinheim) 1994, 327, 91;
(d) Hitotsuyanagi, Y.; Naka, Y.; Yamagami, K.; Fujii, A.; Tahara, T. J. Chem. Soc., Chem. Commun. 1995, 49; (e) Bertounesque, E.; Imbert, T.;
Monneret, C. Tetrahedron 1996, 52, 14235; (f) Miller, T. A.; Vachaspati, P. R.; Labroli, M. A.; Thompson, C. D.; Bulman, A. L.; Macdonald, T. L.
Bioorg. Med. Chem. Lett. 1998, 8, 1065; (g) Hitotsuyanagi, Y.; Kobayashi, M.; Fukuyo, M.; Takeya K.; Itokawa, H. Tetrahedron Lett. 1997, 38,
8
295; (i) Garzino, F.; Méou, A.; Brun, P. Tetrahedron Lett. 2002, 43, 5049; (j) Sarkar, T. K.; Basak, S.; Panda, N. J. Org. Chem. 2003, 38, 6919; (k)
Routier, J.; Calancea, M.; David, M.; Vallée, Y.; Denis, J.-N. Eur. J. Org. Chem. 2008, 5687; (l) Lima, H. M.; Sivappa, R.; Yousufuddin, M.; Lovely,
C. J. Org. Lett. 2012, 14, 6210.
6
7
.
.
(a) Patre, R. E.; Gawas, S.; Sen, S.; Parameswaran, P. S.; Tilve, S. G. Tetrahedron Lett. 2007, 48, 3517; (b) Torney, P. S.; Patre, P. E.; Parmeswaran,
P. S.; Tilve, S. G. Synlett 2011, 639; (c) Parvatkar, P. T.; Kadam, H. K.; Tilve, S. G. Tetrahedron 2014, 70, 2857; (d) Parvatkar P. T.; Torney, P. S.;
Tilve, S. G. Curr. Org. Synth. 2013, 10, 288; (e) Horak, Y. I.; Lytvyn, R. Z.; Homza, Y. V.; Zaytsev, V. P.; Mertsalov, D. F.; Babkina, M. N.;
Nikitina, E. V.; Lis, T.; Kinzhybalo, V.; Matiychuk, V. S.; Zubkov, F. I.; Varlamov, A. V.; Obushak, M. D. Tetrahedron Lett. 2015, 56, 4499 and
references mentioned therein; (f) Zubkov, F. I.; Nikitina, E. V.; Varlamov, A. V. Russ. Chem. Rev. 2005, 74, 639; (g) Zubkov, F. I.; Nikitina, E. V.;
Galeev, T. R.; Zaytsev, V. P.; Khrustalev, V. N.; Novikov, R. A.; Orlova, D. N.; Varlamov, A. V. Tetrahedron 2014, 70, 1659.
General Procedure for the preparation of substituted cinnamyl phosphoranes 6a-d:
A solution of substituted cinnamyl alcohol (1 mmol) and pyridine (1 mmol) in dry chloroform (20 mL) was cooled to 0 °C. Bromoacetyl bromide (1
mmol) was added dropwise with stirring over a period of 15 min. The mixture was stirred for 1 h at 0 °C and further at room temperature for 1 h. To
the reaction mixture, water (20 mL) was added and extracted with chloroform (2 × 25 mL). The organic layer was washed with 2N HCl (2 × 15 mL),
sat. sodium bicarbonate (2 × 20 mL) and finally with water (20 mL). The chloroform layer was dried over anhyd. sodium sulfate. Evaporation of the
solvent under vacuum gave crude cinnamyl 2-bromoacetate which was as such used for the next reaction. The solution of cinnamyl 2-bromoacetate (1
mmol) and triphenylphosphine (1.05 mmol) in dry toluene (20 mL) was stirred overnight at room temperature. The salt formed was filtered and
dissolved in methanol (5 mL). To this water (20 mL) and toluene (40 mL) was added, followed by addition of 2N sodium hydroxide solution with
stirring to phenolphthalein end point. The toluene layer was separated and the aqueous layer was extracted with toluene (2 × 20 mL). The toluene
layer was dried over anhyd. sodium sulfate and the solvent removed under vacuum to give substituted cinnamyl (triphenylphosphoranylidene)acetate.
General procedure for the preparation of tricyclic γ- lactones 8-11 and 13-16:
A solution of indolecarboxaldehyde (1 mmol) and phosphorane 6a-d (1.5 mmol) in diphenyl ether (10 mL) was refluxed for 1-2 h. The crude mixture
was subjected to column chromatography over silica gel using hexanes to remove diphenyl ether first and further elution with 30-50% ethyl acetate in
hexanes to afford diastereomeric γ-lactones.
General procedure for the preparation of indole based heterolignans 12a-d and 17a-d
A mixture of tetrahydrolignans (1 mmol) and DDQ (2.5 mmol) in dioxane (10 mL) was refluxed for 2 h. The reaction mixture was allowed to cool to
ambient temperature and filtered. The filtrate was then concentrated under reduced pressure and resulting residue was dissolved in ethyl acetate (50
mL) and washed with sat. sodium bicarbonate (2 × 10 mL) and water (2 × 10 mL). The organic layer was dried over anhyd. sodium sulfate and
concentrated under reduced pressure. The resulting residue on purification using flash chromatography with hexanes/ethyl acetate gave the oxidized
products.
8
.
Crystal data for 8a: C20H17NO , M = 303.35, monoclinic, space group P 2 /c, a = 12.879(3) Å, b = 6.2881(14) Å, c = 19.076(4) Å, β = 93.163(4)º, V
2
1
3
3
-
1
=
(
deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 1453376. Copies of the data can be obtained,
free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1 EZ, UK. (fax: +44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).
Supplementary Material
1
13
Supplementary data (experimental procedures and characterization data, copies of H, C NMR spectra and structure protocol of 8a)
associated with this article can be found, in the online version, at